Grand Rounds

We are honored to welcome guest speakers from around the country and the world to share their expertise in neurological subspecialties. Residents, trainees and faculty listen to weekly educational sessions with guest speakers who are leaders in their subspecialty, from academic medical centers around the country.

Our 2026-27 guest speakers (updated as speakers are scheduled, in chronological order):

• Dr. Syed Faaiz Enam, MD, PhD, UCLA: "Two Stories of Engineering in Neurology: Cooling Glioblastoma and Upgrading our Trömner"
• Dr. Adys Mendizabal, MD, MS, UCLA: "Artificial Intelligence and Health Equity in Neurology"
• Dr. Anand Suresh, PhD, UCLA: "Translatome profiling reveals opposing alterations in inhibitory and excitatory neurons of fragile X mice and identifies EPAC2 as a therapeutic target"
• Dr. William P. Flavin, MD, PhD, UCLA: "Concussion, CTE, and Tau Polymorphism"
• Dr. Jeffrey L. Saver, MD, FAHA, FAAN, FANA, UCLA: "The Shape of Things to Come: What's Next in Acute Ischemic Stroke After the Reperfusion Revolution"
• Dr. Gopal Thinkaran, PhD, University of South Florida: "The Complex Genetic Architecture of Alzheimer's Disease: What Is the Risk?"

Our 2025-26 guest speakers:

• Dr. Baruc Campos, PhD, UCLA: "The role of Parvalbumin interneurons in experience-dependent plasticity and circuit remapping after stroke"
• Dr. Aye Theint Theint, PhD, UCLA: "Impairments in Visual Perception and Cortical Circuit Function in a model of Parkinson’s Disease Dementia"
• Dr. Kazi Hasan, PhD, UCLA: "The Pesticide Chlorpyrifos Increases the Risk of Parkinson’s Disease"
• Dr. Tirth Patel, MD, PhD, UCLA: "Critical role of cerebral lymphovascular system in brain health and tau-induced neurodegeneration"
• Dr. Mayank Jog, PhD, UCLA: "Brain stimulation and imaging: A multimodal methodology for understanding the brain and developing treatments for brain disorders"
• Dr. Ricardo Mouro Pinto, PhD, Harvard: ""Somatic repeat expansions as a therapeutic target for trinucleotide repeat disorders"
• Dr. David Liebeskind, MD, MBA, FAAN, FAHA, FANA, FSVIN, FWSO, UCLA: "Neurovascular Imaging in 2025"
• Dr. Roger Woods, MD, UCLA: "From BWAS to Biomarker to Bedside: Research Brain Imaging Opportunities for Neurological Disorders"
• Dr. Timothy W. Yu, MD, PhD, Harvard: "N=1 trials and interventional neurogenetics"
• Dr. Claudio Soto, PhD, University of Texas: "Seed Amplification Assays for Alzheimer’s and Parkinson’s diseases: Applications for diagnosis, drug discovery and to understand disease biology"
• Dr. Christopher M. De Giorgio, MD, FAAN, UCLA: "Increasing Cardiovascular Risk and Mortality in Epilepsy"
• Dr. Ronald M. Harper, PhD, UCLA: "Neuromodulation procedures for migraine and cardiovascular control"
• Drs. Yazhen Zhu, MD, PhD, UCLA and Hsian-Rong Tseng, PhD, UCLA: "Harnessing Extracellular Vesicle-Derived Molecular/Functional Signatures for Detecting Neurodegenerative diseases"
• Dr. Ulf Dettmer, PhD, Harvard: "Alpha-Synuclein in Parkinson's Disease: 33 Questions, 34 Answers"
• Lior Shmuelof, Ben-Gurion University: "From Impairment Phenotype to Dosage Effect: Translational Research in Stroke Recovery"
• Dr. Dimitrios Kapogiannis, MD, Johns Hopkins: "Biomarkers of brain metabolism and insulin resistance for assessing interventions for brain aging and ADRD"
• Dr. Wolfgang Singer, MD, Mayo Clinic: "The Evolving Field of Synucleinopathy Biomarkers - Key Towards Successful Disease Modification in Multiple System Atrophy?"
• Dr. Wendy A. Suzuki, PhD, New York University: "The Neuroscience of Exercise"
• Torrance York, MFA: "Art as a Beacon: Naviagting life after a diagnosis of Parkinson's disease"
• Dr. Greg W. Albers, MD, Stanford: "The future of endovascular therapy for stroke"
• Dr. David R. Walt, PhD, Harvard: "Digital Assays for Neurodegenerative Disease Diagnosis"
• Dr. Andrew Craig Charles, MD, UCLA: "New therapies for headache and pain disorders"
• Dr. Tony Wyss-Coray, PhD, Stanford: "Young blood for old brains"
• Dr. Beth Ann Malow, MD, MS, Vanderbilt Univesity: "Sleep in Autism: Practical Steps to Help Families Get the Rest they Need"
• Dr. Un Jung Kang, MD, NYU Langone Health: "α-synuclein Biomarker in Parkinson’s Disease and Related Synucleinopathies"
• Dr. Stephen G. Waxman, MD, PhD, Yale: "Huxley’s science fiction: From the squid giant axon 1952 to non-addictive pain medications 2026"
• Dr. Charles E. Argoff, MD, Albany Medical College: "New Approaches to Oral Analgesics: Why this Matters to Neurologists"
• Dr. S. Thomas Carmichael, MD, PhD, UCLA: "Brain Repair in Stroke and Vascular Dementia"
• Dr. Brian G. Rash, PhD, Longeveron Inc.: "Laromestrocel: A Stem Cell Therapy for Alzheimer's Disease?"
• Dr. Cory Nicholas, PhD, Neurona Therapeutics: "GABAergic Interneuron Cell Therapy for Drug-Resistant Epilepsy"
• Dr. Jeffrey G. Ojemann, MD, University of Washington: "Engineering Neuroplasticity: a 50y bench to bedside story"
• Dr. Armin Curt, University of Zurich: "Predictive enrichment in spinal cord injury trials"
• Dr. Steven Greenberg, MD, PhD, Massachusettes: "One Peptide, Two Pathways: Cerebral Amyloid Angiopathy"
• Dr. Jonathon C. Kao, PhD, UCLA: "Brain-Computer Interface Control with AI Copilots"
• Dr. Anne Milasincic Andrews, PhD, UCLA: "Monitoring serotonin signaling: A journey in time and space"

Our 2024-25 guest speakers:

• Dr. Min Tian, PhD, UCLA: "Deconstructing the Intercellular Interactome in Vascular Dementia for Therapeutic Applications"
• Dr. Naohiko Okabe, PhD, UCLA: "Parvalbumin Interneurons Regulate Rehabilitation-Induced Functional Recovery After Stroke and Identify a Rehabilitation Drug"
• Dr. Mai Yamakawa, MD, UCLA: "Deciphering Cell-Type Specific Causal Disease Process for ALS/FTD"
• Dr. Mirella Diaz-Santos, PhD, UCLA: "From Recruitment Strategies to Multi-Level Interventions: Inclusion, Diversity and Equity in ADRD Clinical Research/Trials"
• Dr. Katherine Fu, MD, UCLA: "Innovations in Neurology Resident Education: Enhancing Transitions to Neurology Residency, Resident Wellness, and Evidence-Based Practice"
• Dr. Kemar E. Green, DO, Johns Hopkins University: "Artificial Intelligence-Enabled Digital Ocular Motor Biomarkers of Neurologic Disease"
• Dr. Erik S. Carlson, MD, PhD, University of Washington: "Resilience and Vulnerability: Cerebellar integrity in Cognitive Aging and in Alzheimer’s Disease Dementia"
• Dr. Ivan Marazzi, MD, PhD, UC Irvine: "Role of RNA catabolism in disease"
• Dr. Guido Angelo Cavaletti, MD, University of Milano-Bicocca: "Neurologic Complications of Non-Neurologic Therapeutics"
• Dr. Jorg Dietrich, MD, PhD, MBA, MMSc, FAAN, FANA, Massachusetts General Hospital Cancer Center: "Neurologic Complications of Non-Neurologic Therapeutics"
• Dr. Lee Goldstein, MD, PhD, Boston University: "Concussion,TBI, and CTE: Insights from the Battlefield, Ball Field & Lab Bench"
• Dr. Hossein Estiri, PhD, Harvard: "Bridging Minds and Machines: "AI Workflows for Unlocking Insights into Cognitive Health from Real-World Data"
• Dr. Nicholas Frost, MD, PhD, University of Utah: "Manifold Disruptions of a Neuronal Ensemble in ASD"
• Dr. Laura Trejo, MD, Los Angeles County Aging and Disabilities: "Responding to Los Angeles County's Aging Population"
• Dr. Guo-Li Ming, MD, PhD, University of Pennsylvania: "Applying Novel Technologies to Understand Neurodevelopment And Neurological Disorders"
• Dr. Amanda C Guidon, MD, MPH, Harvard: "Neuromuscular Toxicities of Immune Checkpoint Inhibitors"
• Dr. James Teo, MA, MB, FRCP, PhD, FFCI, King's College Hospital: "Neurology in the Age of Neural Networks"
• Dr. Chris DeGiorgio, MD, FAAN, UCLA: "Trigeminal Nerve Stimulation: Basic Science and Neuropsychiatric applications"
• Dr. Paul Lukac, MD, MBA, MS, UCLA: "Generative AI in Healthcare: Present and Future"
• Dr. Jorge J. Palop, PhD, UCSF: "Interneuron Dysfunction and Brain Network Abnormalities in Alzheimer’s Disease"
• Dr. Jack M. Parent, MD, University of Michigan: "Modeling Genetic Epilepsies with Human Brain Organoids"
• Dr. Amy F. Kuceyeski, PhD, Weill Cornell Medical College: "Bootstrapping clinical MRI for brain lesion-network-behavior mapping"
• Dr. David J. Reinkensmeyer, PhD, UC Irvine: "Robots and sensors for neurorehabilitation"
• Dr. Michelle J. Johnson, PhD, University of Pennsylvania: "HIV, Aging, and Stroke: Insights from Clinical and Robotic Assessments of Cognitive and Motor Function"
• Dr. Martha Morrell, MD, Stanford University: "Creatinga Brain Responsive Neurostimulator for Epilepsy: A Bench to Bedside Success"
• Dr. Ron Postuma, MD, MSc, McGill University: "RBD - A Window into Early Parkinson’s Disease"
• Dr. Gottfried Schlaug, MD, PhD, FANA, FAHA, FASNR, University of Massachusetts: "Brain Stimulation in Stroke Recovery"
• Dr. Philip A. Starr, MD, PhD, UCSF: "The development of adaptive deep brain stimulation for Parkinson's disease"
• Dr. Li-Huei Tsai, PhD, MIT: "Frequency Matters: Harnessing 40 Hz Stimulation for Alzheimer's Disease and Neuroprotection"
• Dr. Eric Carl Landsness, MD, PhD, Washington University: "Cooling with a Purpose: From Hypothermia to Torpor in Neuroprotection"
• Dr. David R. Liu, PhD, Harvard: "Mutation-Specific, Mutation-Agnostic, and Disease-Agnostic Therapeutic Genome Editing"
• Dr. Samuel Matthew Young Jr., PhD, University of North Carolina: "Presynaptic CaV2 Calcium channels: Elucidating their regulatory roles in synaptic transmission and the development of gene therapy approaches for CaV2 disorders"
• Dr. Claire Dudley Clelland, MD, PhD, MPhil, UCSF: "Developing CRISPR gene therapy for neurodegenerative diseases"
• Dr. Ron Batra, PhD, Dyne Therapeutics: "Delivery of Oligonucleotides for the treatment of neuromuscular diseases"
• Dr. Michael D. Fox, MD, PhD, Harvard: "Mapping and modulating brain circuits for neurological disease"
• Dr. Nicolas Schweighofer, PhD, USC: "Towards AI-based precision rehabilitation post-stroke via patient-predictive modeling"
• Dr. Alexandra Bronwen Nelson, MD, PhD, UCSF: "Dopamine Replacement Therapy for Parkinson's Disease: Complications and Circuit Mechanisms"

Our 2023-24 guest speakers:

• Dr. Jennifer Adrissi, MD, MSCR, UCLA: "Moving the Dial toward Equity in Parkinson’s Disease Research: Current Research and Next Steps"
• Dr. Lisa M. Barnhill, PhD, UCLA: "Understanding Environmental Influencers of Neurodegenerative Disease Risk"
• Dr. Brian Na, MD, UCLA: "Cold plasma exposure for treatment of neurofibromatosis type 1 (NF1) associated peripheral nerve sheath tumors"
• Dr. Mai Yamakawa, MD, UCLA: "Molecular Phenotyping of Rare Peripheral Immune Cells in Alzheimer’s Disease Brain using Single Cell Genomics"
• Dr. Victoria M. Ho, MD, PhD, UCLA: "Cell Type-Specific Transcriptional Changes Underlying Memory Impairment in Temporal Lobe Epilepsy"
• Dr. Clive N. Svendsen, PhD, Cedars-Sinai: "Using iPSCs to model and treat human disease"
• Dr. Ahmet Hoke MD, Ph.D. FRCPC, Merkin Peripheral Neuropathy and Never Regeneration Center: "Axonal Peripheral Neuropathies: etiologies and mechanisms of axon degeneration"
• Dr. Heidi Rehm PhD, FACMG, Harvard: "Advancing Genomic Medicine through Global Collaboration"
• Dr. Joseph G. Gleeson, MD, UCSD: "Pediatric Brain Disease Causes & Treatments"
• Dr. Brent L. Fogel, MD, PhD, UCLA: "Advances in the Genetic Diagnosis of Cerebellar Ataxia"
• Dr. Ajay Sampat, MD, UC Davis: "My ALS Journey: thoughts, reflections and unsolicited advice for neurologists"
• Dr. Jennifer S. Yokoyama, PhD, Memory and Aging Center: "Genetic Contributions to Neurodegenerative Disease"
• Dr. Deanna Saylor, MD, MHS, Johns Hopkins University: "Global Neurology: Developing Neurological Care and Training in Zambia"
• Dr. Ajay Sampat, MD, UC Davis: "My ALS Journey: thoughts, reflections and unsolicited advice for neurologists"
• Dr. Melissa Spencer, PhD, UCLA: "Improving the efficacy and durability of gene editing therapies for Duchenne muscular dystrophy"
• Dr. Niccolo Mencacci, MD, PhD, Northwestern University: "Human genetics define converging molecular pathways in dystonia"
• Dr. Hugh Gelabert, MD, UCLA: "Overview of Thoracic Outlet Syndrome"
• Dr. Wesley Kerr, PhD, UCLA: "Focusing Treatment for Functional Neurological Disorders based on Neuroimaging-Based Pathophysiologic Changes"
• Dr. David L. Perez, MD, PhD, Harvard: "The Neuropsychiatry of Functional Neurological Disorder"
• Dr. Chelsea Richardson, PT, DPT, NCS, re+active: "Interdisciplinary Assessment & Treatment (PT, OT, Psychology) for Individuals with Functional Neurological Disorders"
• Dr. Peter Lansbury, PhD, Harvard: "Development of a Disease-Modifying Drug for GBA-Parkinson’s Disease"
• Dr. Mark Hallett, MD, DM(hon), National Institute of Health: "Etiology and Pathophysiology of Functional Neurological Disorders"
• Dr. Sarah Lidstone, MD, PhD, FRCPC, Univeristy of Toronto: "New Phenotypes, Triage, and Treatment of FMD"
• Dr. Deborah Cory-Slechta, PhD, University of Rochester: "Air Pollution, Brain Metal Dyshomeostasis, and Neurodegeneration"
• Dr. Yakeel Quiroz-Gaviria, PhD, Harvard: "Charting the path for early diagnosis and prevention of Alzheimer’s disease: Findings from the Colombia-Boston Biomarker Study"
• Dr. Beate R. Ritz, MD, PhD, UCLA: "Parkinson’s Diseases And the Environment"
• Dr. Monica Rivera Mindt, PhD, ABPP-CN, Fordham University: "Increasing the External and Internal Validity of Research in Alzheimer"
• Dr. Aisha Dickerson, PhD, Johns Hopkins Bloomberg School of Public Health: "Environmental Neuroepidemiology: A Web of Confusion"
• Dr. David Brody, MD, PhD, Uniformed Services University: "Optimizing Sleep and Treating Mood Dysregulation as a Pathway to Reducing Risk of Neurodegeneration Related to Traumatic Brain Injury"
• Dr. Charlotte J. Sumner, MD, Johns Hopkins University: "The TRPV4 Channel and BloodNeural Barriers"
• Dr. Stephanie Tankou, MD, PhD, Mount Sinai: "The Gut Microbiome: A Novel Therapeutic Target for Multiple Sclerosis"
• Dr. Sally Temple, PhD, Neural Stem Cell Institute: "Using Brain Organoids to Study Tauopathy"
• Dr. Richard Krolewski, MD, PhD, Brigham and Women's Hospital: "Identification and functional characterization of PD-relevant pesticides in iPSC-derived neurons"
• Dr. Philip De Jager, MD, PhD, Columbia University: "Dissecting the Cellular Communities Driving Cognitive Aging in the Human Brain"

Our 2022-23 guest speakers:

• Dr. Nazim Kourdougli, PhD, UCLA: "Improvement of sensory deficits in Fragile X mice by increasing cortical interneuron activity after the critical period"
• Dr. Jason Hinman, MD, PhD, UCLA: "Vascular Cognitive Impairment and Dementia - Past, Present, and Future"
• Dr. Kevin Bickart, MD, PhD, UCLA: "Personalized Frontoamygdala Neuromodulation for Persistent Post-Concussive Symptoms"
• Dr. Margit Alt Murphy, PhD, University of Gothenburg: "Stroke recovery considering motor performance and movement quality"
• Dr. Lewis Wheaton, PhD, Georgia Tech: "Understanding perceptuomotor integration for action observation during rehabilitation: insights from amputation and stroke"
• Dr. Sean Dukelow, MD, PhD, FRCPC, University of Calgary: "Using of robotics and neuroimaging to better understand and augment stroke recovery"
• Dr. Craig Erickson, MD, Cincinnati Children's Hospital Medical Center: "Personalizing medicine in neurodevelopmental disorders"
• Dr. Marion Buckwalter, MD, PhD, Stanford Stroke Center: "Post-Stroke Dementia"
• Dr. Leigh Hochberg, MD, PhD, VA RR&D Center for Neurorestoration and Neurotechnology: "BrainGate: Update on Clinical Trials in Intracortical Brain-Computer Interfaces for the Restoration of Communication and Mobility"
• Dr. Cathy Stinear, PhD, UCL Queen Square Institute of Neurology: "Biomarkers for predicting outcomes in stroke recovery and rehabilitation trials"
• Dr. Steven J. Frucht, MD, NYU Langone Medical Center: "Focal task-specific dystonia: a mysterious disorder of motor control"
• Dr. Eelco F. M. Wijdicks, MD, PhD, Mayo Clinic and Mayo Foundation: "Neurocinema: The History of Neurology on Screen"
• Dr. Laurel J. Buxbaum, PsyD, Thomas Jefferson University: "Limb apraxia: A disorder at the cognitive-motor interface"
• Dr. Irene Litvan, MD, FAAN, FANA, MPhil, UC San Diego: "Why is our Approach Not Working in Disease Modification in Atypical Parkinsonian Disorders?"
• Dr. Marc Diamond, MD, UT Southwestern Medical Center: "Mechanisms of tau prion propagation"
• Dr. D. James Surmeier, PhD, Northwestern University: "Acquired Mitochondrial Dysfunction, Parkinsonism, and Network Determinants of Disability"
• Dr. Alice Chen-Plotkin, MD, University of Pennsylvania: "Molecular Definition for Parkinson Disease"
• Dr. Claire Henchcliffe, MD, DPhil, FAAN, FANA, UC Irvine: "Cell-Based Regenerative Medicine Approaches to Parkinson’s Disease"
• Dr. Adys Mendizabal, MD, MS, UCLA: "Studying Health Disparities in Rare Neurological Conditions"
• Dr. Marc Nuwer, MD, PhD, UCLA: "Changes in documentation and coding for patient visits"
• Dr. Edward F. Chang, MD, UCSF: "Restoring Words: Towards a Speech Neuroprosthesis"
• Dr. Timothy R. Sampson, PhD, Emory University of Medicine: "Delineating gut microbiome contributions to Parkinson's disease pathologies"
• Dr. Paul George, MD, PhD, Stanford University: "Stroke Recovery Therapies: Engineering Approaches to Simplify a Complex Environment"
• Dr. Mark H. Tuszynski, MD, PhD, UCSD: "Neural Stem Cells for Spinal Cord Injury: From Mechanism to Translation"
• Dr. Ashley S. Harms, PhD, University of Alabama at Brimingham: "The role of the immune system in synucleinopathies"
• Dr. Barbara Slusher, PhD, MAS, Johns Hopkins School of Medicine: "JOINING FORCES: the importance of collaborations in academic drug discovery"
• Dr. Todd J. Schwedt, MD, MSCI, American Headache Society: "Post-Traumatic Headache: Diagnosis, Differentiation, and Prognostic Modeling"
• Dr. Wouter I. Schievink, MD, Cedars-Sinai: "Spontaneous Intracranial Hypotension"
• Dr. Joseph P. Broderick, MD, University of Cincinnati: "Team Science and the Future of Stroke Research: the NIH StrokeNet"
• Dr. Jason J. Sico, MD, MHS, FAHA, FAAN, FANA, FACP, Yale: "Big Data, Little Data, and Improving Headache Care Quality and Delivery for Veterans"
• Dr. Peter J. Goadsby, MBBS, MD, PhD, UCLA: "Migraine - New Therapies and Lessons Learned"
• Dr. Andrew Charles, MD, UCLA: "Adenosine, caffeine, and diurnal patterns of brain blood flow and behavior: implications for migraine and other neurological disorders"
• Dr. Anthony Linares, MD, PhD, UCLA: "Spatial Genomic Cell-Type Specific Responses and Interactions in HumanAlzheimer's Disease Brain"
• Dr. Ibrar A. Siddique, PhD, UCLA: "Exophers are components of mammalian cell neurobiology in health and disease"

Our 2021-22 guest speakers:

• Dr. Daniel Tward, PhD, UCLA: "Computational Techniques to Study Neurodegeneration in early Alzheimer's Disease"
• Dr. Mary Teena Joy, PhD, UCLA: "Molecular Encoders of Memory as Therapeutic Targets for Motor Recovery"
• Dr. Keith Vossel, MD, UCLA: "The Latest Advances in Alzheimer’s and Dementia Research"
• Dr. Jiannis Taxidis, UCLA: "Remembering What Happened When: Dynamics of Hippocampal Sequences Linking Memories Across Time "
• Dr. Indu Subramanian, MD, UCLA: "The Power of Social Connection in Neurodegenerative Disease"
• Dr. Christopher Degiorgio, MD, UCLA: "New Secular Trends in Epilepsy Mortality and Causes of Death"
• Dr. Daniel Geschwind, MD, PhD, UCLA: "Achieving Precision Health in Medicine and Neuropsychiatry"
• Dr. John Ravits, MD, UCSD: "Emerging Targeted Gene Therapies in ALS and New Paradigms for Treating Neurodegenerative Disorders "
• Dr. Mitchell Miglis, Stanford: "Autonomic Disorders in Neurodegenerative Disease"
• Dr. Anthony Lang, MD, FRCPC, University of Toronto: "Clinical Trials Targeting Alpha-Synuclein in Parkinson's Disease"
• Dr. Vikram Rao, MD, UCSF: "Cloudy with a Chance of Seizures: Personalized Forecasting in Epilepsy"
• Dr. Sonja Scholz, MD, PhD, NIH/Hopkins: "The genetic architecture of Lewy body dementia: from gene discovery to clinical translation"
• Dr. Helen Bronte Stewart, MD, MS, Stanford: "Closed Loop or Adaptive Deep Brain Stimulation for Parkinson's Disease"
• Dr. Eva Feldman, MD, PhD, University of Michigan: "Opportunities and Challenges in the Treatment of ALS"
• Dr. Sean Pittock, MD, Mayo Clinic: "NMOSD: A Two Decade Journey of Discovery From Biomarker to FDA Approved Drugs"
• Dr. Benjamin Segal, MD, OSU: "Immune Driven Neurorepair"
• Dr. Anne Cross, MD, Washington University: "B Lymphocytes and MS in the Era of COVID-19"
• Dr. Unsong Oh, MD, PhD, VCU: "Multiple Sclerosis"
• Dr. Laurie Gutmann, MD, Indiana University: "Neurology Education: Future Directions"
• Dr. Eugene Yeo, PhD, MBA, UCSD: "RNA Binding Proteins as Regulators, Drugs and Drug Targets"
• Dr. Stephen Hauser, MD, UCSF: "Progressive MS: The Next Frontier"
• Dr. Frances Jensen, MD, University of Pennsylvania: "Reimagining and Rescoping Academic Neurology"
• Drs. S. Thomas Carmichael, MD, PhD, and Paul Vespa, MD, UCLA: "ABPN Brain Death Training"
• Dr. Michael Sperling, MD, Thomas Jefferson University: "Advanced treatment for epilepsy: Thermal ablation, neuromodulation, and focused ultrasound
• Dr. Jeff Noebels, MD, PhD, Baylor: "Exploring the Genetic and Excitability Borderland of Glioblastoma and Epilepsy"
• Dr. Scott Baraban, PhD, UCSF: "Epilepsy & Drug Discovery in Zebrafish"
• Dr. Allison Willis, MD, University of Pennsylvania: "Translational Neuroepidemiology: Using ‘Big’ Data to Understand Neurological Disease Burden and Improve Outcomes"
• Dr. Altaf Saadi, MD, MSc, Massachusetts General: "Supporting Immigrants, Refugees and Asylum-Seekers: A Role for Neurology, Research and Advocacy"
• Dr. Mirella Diaz-Santos, PhD, UCLA: "Spanish-English Bilingualism and Alzheimer's Dementia and Related Disorders (ADRD) in Hispanic/Latinx Communities"
• Dr. Bruce L. Miller, MD: "Advances in Dementia: From Diagnosis to Treatment"
• Dr. John F. Crary, MD, PhD: "Neuropathology of Age-Related Tauopathy"
• Dr. Matthew Shtrahman, MD, PhD, Salk Institute for Biological Studies: "Adeno-Associated Virus (AAV) Toxicity: Implications for Neurodevelopment to Neurodegeneration"
• Dr. Argye Beth Hillis, MD, Johns Hopkins University School of Medicine: "Functions of the Non-Eloquent Hemisphere: Identifying Deficits and Facilitating Recovery"
• Dr. Charlene Gamaldo, MD, Johns Hopkins: "Strategies to Infuse DEI into our DNA: Mechanism for the Neurology Community"
• Dr. David M. Holtzman, MD, Washington University of Medicine: "The Role of APOE in Aβ and Tau Mediated Pathogenesis of Alzheimer’s Disease"
• Dr. Lawrence Steinman, MD, Beckman Center for Molecular Medicine Stanford University: "Molecular Mechanism of How EBV Triggers MS"
• Dr. Jacob T. Robinson, PhD, Baylor College of Medicine: "Minimally Invasive Neural Interfaces"
• Dr. Timothy E. Brown, PhD, UW Medicine: "Neuroprosthetics: Automation, Agency, and Self-Trust"
• Dr. Gretchen L. Birbeck, MD, MPH, DTMH, University of Rochester: "Neuro-HIV in Sub-Saharan Africa: A 25-Year View from the Ground"
• Dr. Matthew Botvinick, MD, PhD, UCL: "Neuroscience Meets Artificial Intelligence"

Our 2020-21 guest speakers:

• Erika Cheung, Ethics in Entrepreneurship: "Speak-Up Culture in Medicine"
• Christer Betsholtz, Uppsala Universitet: "Endothelial - Pericyte Signaling in Microvascular Physiology and Disease"
• Dr. Goncalo Castelo-Branco, PhD, Karolinska Institute: "Oligo Lineage Cells & MS"
• Dr. Keith Vossel, MD, UCLA: "The Future of AD Research at UCLA"
• Dr. Benedict Michael, PhD, University of Liverpool: "CoroNerve Study Group"
• Dr. Richard Benson, MD, PhD, NIH: "NINDS Health Disparities Strategic Planning Process"
• Dr. Jason Hinman, MD, PhD, UCLA: "Cerebrovascular Complications of Sars-CoV-2"
• Dr. Glen Finney, MD, Geisinger Health: "Neurology Advocacy"
• Patricia Furlong, President and CEO, Parent Project Muscular Dystrophy: "The Role of Advocacy in Medicine: a Case Study"
• Dr. Tamika Burrus, MD: "PAC Telemedicine"
• Dr. Deboleena Roy, PhD, Emory: "Molecular Feminisms"
• Dr. Catherine Kaczorowski, PhD, The Jackson Laboratory: "Systems Approach to Identify Resilience-based Targets for Aging and Alzheimer's"
• Dr. Chao Peng, PhD, UCLA: "Conformational Diversity of Pathological Proteins: Input from The Intracellular Environment"
• Dr. Bruce Lamb, PhD, UCLA: "Enhancing the Pre-Clinical Translational Research Pipeline for Alzheimer's Disease Through The MODEL-AD and TREAT-AD Consortia"
• Dr. Guoping Feng, PhD, MIT: "Dissecting neurobiological mechanisms of ASD: from genes to circuits"
• Dr. Michael Lin, MD, PhD, Stanford: "Watching the Brain at Work: New Reporters of Neuronal Activity"
• Dr. Andreas Tolias, PhD, Baylor: "A Less Artificial Intelligence"
• Dr. Lin Tian, PhD, UC Davis: "Watching the Brain in Action: Creating Tools for Functional Analysis of Neural Circuitry"
• Dr. Paul Mathews, PhD, UCLA: "Developing Small Molecule Readthrough Drugs to Treat the Multisystem Disorder Ataxia Telangiectasia (A-T)"
• Dr. Adam Boxer, MD, PhD, UCSF: "Tau Protein As a Target for Neurodegenerative Therapies"
• Dr. Jane Paulsen, PhD, UW Madison: "Unraveling The Earliest Phases of Vascular Cognitive Impairment and Dementia Using CADASIL: A Collaborative NIH Proposal"
• Dr. Carsten Bonnemann, MD, NIH/NINDS: "Gene and Mutation-Specific Precision Therapies:  From GAN to the COL6 Related Dystrophies and Beyond"
• Dr. Iben Lundgaard, PhD, Lund University: "The Glymphatic System, From Mice and Pigs to Humans"
• Dr. Andy Shih, PhD, Children's Hospital Seattle: "Dissecting The Control of Blood Flow Through Brain Capillaries"
• Dr. Robert Hamilton, PhD, Neuroanalytix: "Advanced Analysis of Cerebral Hemodynamics: TCD, Machine Learning, and Robotics"
• Anna Spain Bradley, JD: "Reckoning with Global Racism"
• Dr. Sara Tabrizi, MD, PhD, UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery: "Collins Day/Meeting The Therapeutic Challenge of Huntington's Disease"
• Keener, Bordelon, Flippen, UCLA Health: "UCLA Neurology Education Update"
• Dr. Wesley Kerr, MD, PhD, Dr. Sree Deepthi Muthukrishnan, PhD, Mayo: "Therapeutic Resistance Mechanisms in Glioblastoma"
• Dr. William Dauer, MD, Southwestern University: "From Molecule to Movement: Dissecting the Path from Dystonia Mutation to Motor Circuit Dysfunction"
• Dr. Christian Grefkes: "Brain Reorganization after Stroke"

Our 2019-20 guest speakers:

• Dr. Martin Monti, PhD, UCLA: "Non-Invasive Low Intensity Focused Ultrasound Stimulation in Disorders of Consciousness"
• Dr. Jared Diamond, PhD, UCLA: "Evolution of Human Language from Animal-Proto Languages"
• Dr. David Lynch, MD, PhD, University of Pennsylvania: "Friedreich Ataxia in 2019"
• Dr. Steven Cramer, MD, UC Irvine: "Biomarkers of Stroke Recovery"
• Dr. Gal Bitan, PhD, UCLA: "A Window into the Brain- Biomarkers in Brain-Derived Exosomes Isolated from the Blood"
• Dr. Jin-Moo Lee, MD, PhD, Washington University: "A Genomic Platform for Acute Stroke Drug Discovery"
• Dr. Michael Wolfe, PhD, University of Kansas: "Gamma-Secretase and the Pathogenesis of Alzheimer's Disease"
• Dr. Andrew Mammen, MD, PhD, National Institutes of Health: "Autoimmune Myopathy"
• Dr. Dwight Bergles, PhD, Johns Hopkins: "Oligodendrocyte Dynamics and Repair in the Adult Brain"
• Dr. Conrad Weihl, MD, PhD, Washington University: "Gene Discovery and Disease Modeling in Limb Girdle Muscular"
• Dr. Lee Sweeney, PhD, University of Florida: "Therapeutic Approaches to Treating Duchenne Muscular"
• Dr. Charles Czeisler, MD, PhD, Harvard: "Work Hours Regulations and Patient Safety in Residency Training: What is the Role of Sleep?"
• Dr. Joshua Sasine, MD, PhD, UCLA: "Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)"
• Dr. Wayne Cornblath, MD, University of Michigan: "NeuroOpthalmology in the 21st Century"
• Dr. Krystal Huxlin, PhD, University of Rochester: "Efficacy, Dynamics, and Limitations of Visual Restoration in Hemianopia"
• Dr. Marc Dinkin, MD, Cornell: "Retrograde Trans-Synaptic Degeneration in the Human Visual System"
• Dr. Sashank Prasad, MD, Harvard: "The History and Mystery of Cortical Visual Disorders"
• Dr. Emily Dennis, PhD, USC: "Collaborative Approaches to Advance Neuroimaging in Traumatic Brain Injury"
• Dr. Peter Douglas, PhD, UT Southwestern: "Metabolic Preconditioning Protects Against Traumatic Brain Injury"
• Dr. Mark Burns, PhD, Georgetown: "Long Term Synaptic Modification Drives Cognitive Impairment After High-Frequency Head Impact"
• Dr. Sandra Rieger, PhD, University of Miami: "Jekyll & Hyde Functions of Hydrogen Peroxide: At the Crossroads of Peripheral Sensory Axon De- and Regeneration"
• Dr. Juliane Gust, MD, PhD, Seattle Children's: "CART Cell Neurotoxicity: Translational Insights"
• Dr. Darrin Lee, MD, USC: "Deep Brain Stimulation for Alzheimer’s Disease: Understanding Circuit Dysfunction"
• Drs. David Liebeskind, MD, and Elyse Singer, MD, UCLA: "Neurologic Complications of COVID-19"
• Dr. William Zeiger, MD, PhD, UCLA: "Functional remapping of the mouse somatosensory cortex after ischemic stroke"
• Cassandra Meyer, PhD candidate, UCLA: "A Mechanism of Estriol-Mediated Neuroprotection in a Mouse Model of Multiple Sclerosis"
• Dr. Katrina Choe, PhD, UCLA: "Unraveling mechanisms of social deficits in genetic models of autism spectrum disorders"
• Dr. Wesley Kerr, MD, PhD, UCLA: "An evidence-based history to identify patients with probable dissociative seizures"
• Dr. Kathryn Cross, MD, PhD, UCLA: "Pallidocortical Activity During Action Selection in Parkinson’s Disease"
• Dr. Amy Gleichman, PhD, UCLA: "Astrocyte heterogeneity after stroke: implications for neural repair"
• Dr. Robyn Klein, MD, PhD, Washington University: "Neuroimmune Mechanisms of Cognitive Dysfunction"
• Dr. Robert H. Brown, Jr., MD, University of Massachusetts: "A 2020 Perspective on ALS from Molecules Toward Medicines"
• Dr. Malu G. Tansey, PhD, University of Florida: "Targeting Soluble TNF to Reduce Risk for Alzheimer’s Disease"
• Dr. Yakeel Quiroz, PhD, Harvard University: "Brain imaging and biomarkers in preclinical autosomal dominant Alzheimer's disease"